Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ATH434 protects brain cells and improves motor function in Parkinsonian disorder 2021-04-21 20:11
Seed Health Closes $40 Million in Series A Financing to Launch New Categories, Accelerate Global Distribution and Expand Clinical Research 2021-04-21 20:00
Seed Health Closes $40 Million in Series A Financing to Launch New Categories, Accelerate Global Distribution and Expand Clinical Research 2021-04-21 20:00
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life." 2021-04-21 19:00
GenScript ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme 2021-04-21 11:08
Ascentage Pharma to Announce Results from Four Clinical Studies at 2021 ASCO Annual Meeting, with Data of Its Drug Candidates Including Lisaftoclax (APG-2575) to Be Released in Oral Presentations for the First Time 2021-04-21 08:38
China Biologic Announces Completion of Going Private Transaction 2021-04-21 04:30
Transcenta Received IND Clearance from US FDA for Initiating Phase I Clinical Trial for its Bi-functional Anti-PD-L1/TGF-β Antibody TST005 2021-04-20 20:54
Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day 2021-04-20 20:00
Prenetics Signs Multi-million Dollar Collaboration with Oxford University for Advanced Molecular Diagnostics 2021-04-20 09:00
AACR 2021-ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration 2021-04-20 08:30
Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform 2021-04-20 05:00
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Financial Officer 2021-04-20 01:42
AACR Annual Meeting 2021: AnchorDx Unveils High-Performance Blood Test for Gastric Cancer Screening 2021-04-19 21:00
CNPharm has succeeded in maintaining IC100 for 24 hours with one injection 2021-04-19 20:15
Porton Biologics Announces Closing Series-A Financing to Drive Commercial Production of Gene and Cell Therapy 2021-04-19 20:00
PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC 2021-04-19 20:00
Kazia Licenses Global Rights to EVT801, a Novel, First-in-Class, Clinic-Ready, VEGFR3 Inhibitor, from Evotec SE 2021-04-19 17:54
RDIF and Hualan Biological Bacterin agree to produce over 100 million doses of the Sputnik V vaccine in China 2021-04-19 17:16
Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Gastric Cancer 2021-04-19 08:00
1 248 249 250 251 252 451